(VSTM:Consolidated Issue listed on NASDAQ Global Market)
Henri A. Termeer
Lead Director and Chairman of Nominating & Corporate Governance Committee,Verastem, Inc.
|Age||Total Calculated Compensation||This person is connected to 306 board members in 17 different organizations across 20 different industries.|
See Board Relationships
Mr. Henri A. Termeer has been the Chief Advisor at CANbridge Life Sciences Ltd., since September 26, 2013. Mr. Termeer has been the Chief Executive Officer of Sanofi Biosurgery since December 1985 and has also been its Chairman and President since May 1988 and October 1983, respectively. He is the Founder of Lysosomal Therapeutics Inc. He served as the Chief Executive Officer and President of Genzyme Tissue Repair and Genzyme General since December 1985 and October 1983 ...
117 Kendrick StreetPhone: 781-292-4200
Needham, Massachusetts 02494
Board Members Memberships*
Executive Director, Member of Strategic Planning & Capital Allocation Committee and Member of Risk Oversight Committee
Chairman, Chief Executive Officer and President
Independent Director, Member of Executive Committee, Member of Compensation Committee and Member of Audit Committee
Lead Outside Director, Member of Nominating & Governance Committee and Member of Compensation Committee
Lead Director and Chairman of Nominating & Corporate Governance Committee
Independent Director, Chairman of Corporate Governance & Compliance Committee and Member of Organization & Compensation Committee
Colgate W. Darden Graduate School of Business Administration
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|